Search

Search Constraints

You searched for: Author/Creator Albanesi, Cristina

Search Results

1. HLA-Cw6 and other HLA-C alleles, as well as MICB-DT, DDX58, and TYK2 genetic variants associate with optimal response to anti-IL-17A treatment in patients with psoriasis. (1st February 2021)

2. IL-38 has an anti-inflammatory action in psoriasis and its expression correlates with disease severity and therapeutic response to anti-IL-17A treatment. Issue 11 (November 2018)

3. Interleukin‐17 and interleukin‐22 promote tumor progression in human nonmelanoma skin cancer. Issue 3 (16th January 2015)

4. Low-Frequency Low-Intensity Ultrasounds Do Not Influence the Survival and Immune Functions of Cultured Keratinocytes and Dendritic Cells. (1st December 2009)

5. Paradoxical psoriasis induced by TNF‐α blockade shows immunological features typical of the early phase of psoriasis development. (29th October 2019)

7. Selective Immunomodulation of Inflammatory Pathways in Keratinocytes by the Janus Kinase (JAK) Inhibitor Tofacitinib: Implications for the Employment of JAK-Targeting Drugs in Psoriasis. (19th November 2018)

8. The phosphoinositide-3-kinase (PI3K)-delta inhibitor seletalisib impairs monocyte-derived dendritic cells maturation, APC function, and promotes their migration to CCR7 and CXCR4 ligands. Issue 3 (24th February 2022)

9. The phosphoinositide‐3‐kinase (PI3K)‐delta inhibitor seletalisib impairs monocyte‐derived dendritic cells maturation, APC function, and promotes their migration to CCR7 and CXCR4 ligands. Issue 3 (24th February 2022)

10. Therapeutical potential of a peptide mimicking the SOCS1 kinase inhibitory region in skin immune responses. Issue 7 (28th May 2013)